Thomas Svoboda
Head of Investor Relations
Replay available
AMG Critical Materials N.V. (OTC: AMVMF) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chairman of the Management Board & Chief Executive Officer
Chief Corporate Development Officer
Chief Financial Officer
Analyst, DeGroof Petercam
Analyst, Deutsche Bank
Good day, everyone, and welcome to today's AMG Q4 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing the star and 1 on your telephone keypad. Please note, this call is being recorded, and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Thomas Svoboda. Please go ahead, sir. Thank you, Paul. Good day, everyone. Welcome to AMG's first quarter 2025 earnings call. It is a very busy reporting day, we are aware of that, so we appreciate you taking your time for us. Joining me on this call is the entire AMG management board. namely Dr. Heinz Schimmelbus, the Chairman of the Management Board and Chief Exec. Officer, Mr. Jackson Dunkle, the Chief Financial Officer, and Mr. Michael Connor, the Chief Corporate Development Officer. We published our fourth quarter 2025 earnings press release yesterday, along with a presentation for investors, both of which you can find on our website. They include our disclaimers about forward-looking statements. Today's call will begin with a review of the first quarter 2025 business highlights by Dr. Schimmerbusch. Mr. Conon will comment on strategy and Mr. Danko will comment on AMG's financial results. At the completion of Mr. Danko's remarks, Dr. Schimmerbusch will comment on outlook. We will open the line to take your questions thereafter. I will now pass the floor to Dr. Schimmelbusch, AMG's Chairman of the Management Board and Chief Exec Officer. Dr. Schimmelbusch. Thank you, Thomas. In 2025, we achieved the third highest adjusted EBTA in the company's history, despite weakness in lithium and...